ELI LILLY & Co (LLY) stock
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3024% above fair value
$1443.50+16.22 (+1.14%)
Close on Nov 13, 2026Market cap $1.36TP/E 46.9Yield 0.43%
Eli Lilly enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Eli Lilly's enterprise value was $1.33T on Nov 11, 2026, against $1.00T a year earlier. Over the last 5 years it ranged from $237.25B to $1.33T, with a median of $724.77B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.33T | +33.4% |
| 2025 | Dec 31, 2025 | $1.00T | +37.9% |
| 2024 | Dec 31, 2024 | $725.74B | +33.4% |
| 2023 | Dec 29, 2023 | $543.96B | +57.8% |
| 2022 | Dec 30, 2022 | $344.76B | +29.9% |
| 2021 | Dec 31, 2021 | $265.36B | +58.4% |
| 2020 | Dec 31, 2020 | $167.51B | +18.2% |
| 2019 | Dec 31, 2019 | $141.66B | +13.7% |
| 2018 | Dec 31, 2018 | $124.58B | +29.8% |
| 2017 | Dec 29, 2017 | $95.98B | +15.3% |
| 2016 | Dec 30, 2016 | $83.27B | -11.1% |
| 2015 | Dec 31, 2015 | $93.68B | +23.8% |
| 2014 | Dec 31, 2014 | $75.65B | +29.5% |
| 2013 | Jan 31, 2013 | $58.42B | +9.1% |
| 2012 | Dec 31, 2012 | $53.55B | – |
See a number that looks wrong?